Home > Press > Enable IPC Ultracapacitor Exceeds 1 Million Cycles
Abstract:
Exclusive License Expands Fields of Use for Both Consumer and Industrial Applications; Opens $600 Million Potential Market
Enable IPC Corporation (OTCBB: EIPC) announced today that its ultracapacitor technology has matched or exceeded the cycle life of commercially-available devices.
"As a point of reference, many rechargeable batteries have a useful life in the 1000s of cycles," explained researcher Kevin Leonard, one of the inventors of the Enable IPC ultracapacitor. "That is, you can charge and discharge them at most a few thousand times before they are no longer useful.
"Ultracapacitors, on the other hand, can generally be charged and discharged hundreds of thousands of times. In our laboratory testing, on the morning of December 13th, our ultracapacitor surpassed 1 million cycles while still maintaining over 80% of its initial capacity, which matches some of the best performance reports we've seen in ultracapacitor life cycle testing."
The company is continuing the testing to determine how many cycles the devices can withstand.
Enable IPC CTO, Dr. Mark Daugherty, said, "We are very pleased with the pace of our ultracapacitor development. We've met our performance milestones and are actively developing exciting new applications to take advantage of these recent improvements."
Separately, Enable IPC recently announced that they had completed and signed the final license agreement with the University of Wisconsin, exclusively securing the ultracapacitor technology for consumer and industrial applications for the useful life of the patent.
To receive corporate updates and be added to Enable IPC's corporate e-mail list for shareholders and interested investors, please send an e-mail to .
####
About Enable IPC Corporation
Enable IPC Corporation turns technologies into products. The Company has licensed an ultracapacitor technology that utilizes nanoparticles on carbon sheets to lower costs and significantly improve performance. In addition, the Company has a patent application on a proprietary concept that combines thin film manufacture with nanotechnology to produce a microbattery that the company believes will significantly outperform comparable products and revolutionize the microbattery industry.
Forward-Looking Statements: This release contains forward-looking statements, such as "believes," "should" and similar terminology, which are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. These forward-looking statements involve risks and uncertainties which could cause actual results that the Company achieves to differ materially from any of the forward-looking statements. Such risks and uncertainties, include, but are not limited to, the following: the timely development and market acceptance of products and technologies, the ability to secure additional sources of financing, the difficulties in forecasting results from development efforts, difficulties in accurately estimating market growth, the impact of changing economic conditions, business conditions in the microbattery and ultracapacitor industries and others identified in our Annual Report on Form 10-KSB, as amended, and other Securities and Exchange Commission filings. The Company undertakes no obligations to revise or update any forward-looking statements in order to reflect events or circumstances that may arise after the date of this release.
For more information, please click here
Contacts:
Enable IPC Corporation
Rich Kaiser
800-631-8127
Investor Relations
Copyright © Marketwire
If you have a comment, please Contact us.Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.
Related News Press |
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Patents/IP/Tech Transfer/Licensing
Getting drugs across the blood-brain barrier using nanoparticles March 3rd, 2023
Metasurfaces control polarized light at will: New research unlocks the hidden potential of metasurfaces August 13th, 2021
Arrowhead Pharmaceuticals Announces Closing of Agreement with Takeda November 27th, 2020
Battery Technology/Capacitors/Generators/Piezoelectrics/Thermoelectrics/Energy storage
What heat can tell us about battery chemistry: using the Peltier effect to study lithium-ion cells March 8th, 2024
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||